Searched for
POST MARKETING TRIALS
Homegrown cocoa, coconut milk, jaggery: How Bengaluru techie couple quit their jobs and built a dairy-free, organic chocolate brand from scratchA Bengaluru IT couple, Swathi Kallegundi and Balasubrahmanya PS, have built a thriving organic chocolate brand, Anuttama, over six years. L...- Inside the chaotic Iran talks that let Trump claim victory, but not yet peacePresident Trump announced the end of the Iran War and the reopening of the Strait of Hormuz, following intense Qatari mediation. Despite Is...
- Forget the DOJ. For a Trump pardon, call "Bobby" and other influencersPresident Donald Trump's pardon system has shifted dramatically. Influence now hinges on personal networks and narratives of victimhood, by...
- ET Prime Special Series: Multibagger or IBC - Part 59: Japan taught it. Tata bought it. Now EVs will test this auto ancillaryThis is a story about a company that is simultaneously an asset and an anomaly. An asset because it builds a tangible, necessary product, g...
- 'Marriage will not work...': Thyrocare's Rs 5,000 crore man Dr A Velumani, reveals the common problem behind stagnant Rs 100 crore firms, according to himThyrocare founder Dr. A. Velumani observed that many profitable Indian companies with revenues over Rs 40 crore are stagnating due to exces...
- US stocks today: US market gains as semiconductor stocks rebound, Middle East tensions easeMajor Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- IT’s Rs 18 lakh crore m-cap rout; Info Edge, Ixigo post Q4 profitsA multi-month bear market has hit the valuations of India’s top 10 digital and technology services exporters. This and more in today’s ETte...
- Top cases on the United States Supreme Court's docketThe U.S. Supreme Court is reviewing significant cases. These cases cover voting rights, presidential authority, immigration policies, and g...
- US stocks today: Nasdaq falls as technology stocks slide, Treasury yields climbUS stocks closed mixed as Nasdaq slipped due to profit booking and rising Treasury yields, while Dow edged higher. Oil prices surged on sup...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- He applied for 3 years straight, got rejected and never gave up — what finally happened will move you to tearsAfter three years of relentless job searching and numerous rejections, a Gen X professional finally received a job offer, a story that deep...
- Elon Musk, Tim Cook and other prominent US executives invited to join Trump on trip to ChinaPresident Donald Trump embarks on a trip to China this week to meet President Xi Jinping. Several prominent US executives from technology a...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- InstaHelp pushes Urban Company's growth but drags overall profitabilityUrban Company's InstaHelp service saw rapid growth in the March quarter. This expansion led to a significant increase in net losses. The co...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
Load More
